John Leheup Archibald

This inventor holds 43 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignee: John Wyeth Brother, Limited. Active years: 1976-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Leheup Archibald. Retrieved from https://idiyas.com/inventor/john-leheup-archibald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 10

Forward Citations = 312(Granted Patents)

Location History:

Windsor, EN (1976 - 1978)
Windsor, GB (1978 - 1984)
Farnham Royal, GB (1984 - 1991)
Farmham Royal, GB (1993)

Company Filing History:

43 out of 299

John Wyeth Brother, Limited

patents

Years Active: 1976-1993

Loading Chart...

Areas of Expertise:

Piperidine Derivatives

Dihydropyridines

Indole Derivatives

Quinoline Carboxamides

Anti-Depressant Agents

Hypotensive Compositions

Heterocyclic Compounds

Piperidyl Ureas

Thiazolotriazine Derivatives

Beta-Adrenergic Blocking

Sulphonamidopiperidyl Indoles

Pharmaceutical Compositions

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5212179 - Piperidine derivatives (1993-05-18),

2. 5068337 - 1,4-dihydropyridines and their ability to inhibit blood platelet (1991-11-26),

3. 5064842 - 1,4-dihydropyridines (1991-11-12),

4. 4985438 - Pyridyl-and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof (1991-01-15),

5. 4900750 - 1.4-Dihydropyridines (1990-02-13),

6. 4866075 - Indole derivatives (1989-09-12),

7. 4806552 - Pyridyl- and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof (1989-02-21),

8. 4801595 - Quinoline carboxamides and anti-hypertensive compositions thereof (1989-01-31),

9. 4778802 - Heterocyclic compounds (1988-10-18),

10. 4772617 - Indole derivatives (1988-09-20),

11. 4722930 - 3-benzoyl-1-[(oxo or thioheteroaryl-ylalkyl)-piperid-4-yl]ureas and (1988-02-02),

12. 4694012 - Method of treating of preventing diseases using 1,4-dihydropyridines (1987-09-15),

13. 4454139 - .alpha..sub.2 -Adrenoceptor antagonistic benzoquinolizines (1984-06-12),

14. 4447604 - Thiazolotriazine derivatives (1984-05-08),

15. 4426387 - Piperid-4-yl ureas and thio ureas used as anti-depressant agents (1984-01-17),

Title: John Leheup Archibald: Innovator in Psychotropic Compounds

Introduction: John Leheup Archibald, based in Windsor, England, is a prolific inventor known for his contributions to the field of psychotropic compounds. With an impressive portfolio of 43 patents, Archibald has made significant strides in the preparation of novel chemical compounds aimed at enhancing mental health.

Latest Patents: Archibald’s latest inventions include the development of Piperidine derivatives, which are aimed at creating compounds of formula ##STR1## and their acid addition and quaternary ammonium salts. These compounds display psychotropic activity and are particularly noted for their potential as antidepressants. Additionally, he has worked on 1,4-dihydropyridines and their ability to inhibit blood platelets. This work signifies his involvement in cutting-edge research with beneficial medical applications.

Career Highlights: Archibald is associated with John Wyeth & Brother Limited, where his innovative research plays a vital role in the company’s efforts to advance therapeutic solutions. His focus on psychotropic agents reflects a growing need for effective antidepressants in modern medicine, showcasing his commitment to improving mental health outcomes.

Collaborations: Throughout his career, Archibald has collaborated with notable colleagues including Terence J Ward and John Lambert Jackson. These partnerships have likely facilitated innovative thinking and contributed to the successful development of their collective projects in the pharmaceutical field.

Conclusion: John Leheup Archibald's influence in the realm of psychotropic compound development is noteworthy. His ongoing efforts to enhance therapeutic options through his patents not only underscore his role as a key inventor but also highlight the importance of collaboration in scientific advancements. With a strong backdrop of innovative work, Archibald continues to impact the fields of chemistry and medicine.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]